| dc.contributor.author | Pena-Silva, R | |
| dc.contributor.author | Duffull, SB | |
| dc.contributor.author | Steer, AC | |
| dc.contributor.author | Jaramillo-Rincon, SX | |
| dc.contributor.author | Gwee, A | |
| dc.contributor.author | Zhu, X | |
| dc.date.accessioned | 2020-12-16T23:51:26Z | |
| dc.date.available | 2020-12-16T23:51:26Z | |
| dc.date.issued | 2020-07-17 | |
| dc.identifier.citation | Pena-Silva, R., Duffull, S. B., Steer, A. C., Jaramillo-Rincon, S. X., Gwee, A. & Zhu, X. (2020). Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 87 (3), pp.1589-1590. https://doi.org/10.1111/bcp.14476. | |
| dc.identifier.issn | 0306-5251 | |
| dc.identifier.uri | http://hdl.handle.net/11343/254596 | |
| dc.language | English | |
| dc.publisher | WILEY | |
| dc.title | Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19 | |
| dc.type | Journal Article | |
| dc.identifier.doi | 10.1111/bcp.14476 | |
| melbourne.affiliation.department | Paediatrics (RCH) | |
| melbourne.source.title | British Journal of Clinical Pharmacology | |
| melbourne.source.volume | 87 | |
| melbourne.source.issue | 3 | |
| melbourne.source.pages | 1589-1590 | |
| melbourne.elementsid | 1458835 | |
| melbourne.openaccess.url | https://europepmc.org/articles/PMC7404744?pdf=render | |
| melbourne.openaccess.status | Published version | |
| melbourne.contributor.author | Steer, Andrew | |
| melbourne.contributor.author | Gwee, Amanda | |
| dc.identifier.eissn | 1365-2125 | |
| melbourne.accessrights | Access this item via the Open Access location | |
